Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Kynuramine: high affinity for [3H]tryptamine binding sites.

K G Charlton, T D Johnson, R W Maurice

    European Journal of Pharmacology
    |November 27, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Effects of Fission Yield Data in the Calculation of Antineutrino Spectra for ^{235}U(n,fission) at Thermal and Fast Neutron Energies.

    Physical review letters·2016
    Same author

    Fabrication and characterization of injectable hydrogels derived from decellularized skeletal and cardiac muscle.

    Methods (San Diego, Calif.)·2015
    Same author

    Effectiveness of a vegetable dental chew on periodontal disease parameters in toy breed dogs.

    Journal of veterinary dentistry·2012
    Same author

    The Brøset Violence Checklist: clinical utility in a secure psychiatric intensive care setting.

    Journal of psychiatric and mental health nursing·2010
    Same author

    Chronic bilateral basal pulmonary fibrosis; clinical study.

    Proceedings [of the] annual meeting. Central Society for Clinical Research (U.S.)·2010
    Same author

    Seasonal allergies and suicidality: results from the National Comorbidity Survey Replication.

    Acta psychiatrica Scandinavica·2009
    Same journal

    Baicalin downregulates Thromboxane A<sub>2</sub> receptor via SIRT1/NRF2 and NLRP3 pathways to attenuate Cyclosporine A-induced hypertension.

    European journal of pharmacology·2026
    Same journal

    ARBUTIN AS A THERAPEUTIC CANDIDATE FOR AUTISM: CURRENT EVIDENCE AND MECHANISTIC INSIGHTS INTO PI3K/Akt/mTOR and Nrf2 PATHWAYS.

    European journal of pharmacology·2026
    Same journal

    Repeated Ethanol Exposure in Female Rats Impairs Cerebral Endothelial Function and Increases Cerebrovascular Stiffness.

    European journal of pharmacology·2026
    Same journal

    Valerenic acid attenuates chronic stress-exacerbated metabolic dysfunction-associated steatotic liver disease via the estrogen receptor α-GDF15 axis.

    European journal of pharmacology·2026
    Same journal

    Theranekron Prevents Endotoxin-Induced Acute Kidney Injury by Modulating Inflammatory and Mitochondrial Apoptotic Pathways.

    European journal of pharmacology·2026
    Same journal

    Icariside Ⅱ alleviates heart failure based on Wnt/β-catenin-mitochondrial apoptotic pathway.

    European journal of pharmacology·2026
    See all related articles

    Kynuramine, an L-tryptophan metabolite, binds to rat brain sites, suggesting a role in physiological actions. This indicates kynuramine may act via the newly identified tryptamine receptor.

    Area of Science:

    • Neuroscience
    • Biochemistry
    • Pharmacology

    Background:

    • L-tryptophan is metabolized into kynuramine.
    • Kynuramine's physiological roles are not fully understood.
    • Tryptamine receptors are putative targets for neurotransmission.

    Purpose of the Study:

    • To investigate the binding affinity of kynuramine to rat brain receptors.
    • To determine the specificity and selectivity of kynuramine binding.
    • To explore the potential role of kynuramine in tryptaminergic signaling.

    Main Methods:

    • Radioligand binding assays were performed using [3H]tryptamine.
    • Kynuramine's inhibition constant (Ki) was determined.
    • Competitive binding was assessed against other neurotransmitter receptors.

    Related Experiment Videos

    Main Results:

    • Kynuramine displaced [3H]tryptamine from high-affinity binding sites with a Ki of 28 nM.
    • Kynuramine demonstrated structural specificity and selectivity.
    • No significant affinity was observed for serotonergic, adrenergic, or benzodiazepine sites.

    Conclusions:

    • Kynuramine interacts with a specific binding site in the rat brain cortex.
    • This binding site is likely the putative tryptamine receptor.
    • Kynuramine may mediate physiological effects through this receptor, opening new research avenues.